|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Inhibition of mierosomal triglyceride transfer protein in familial hyper-cholesterolemia显示文摘 | Cuchel M Bloedon LT Szapary PO | 2007 | N Engl J Med2007，356，2： | 1 |
| 2 | Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia 显示文摘 | Cuchel M Bloedon LT Szapary PO el al | 2007 | N Engl J Med2007，356，： | 1 |
| 3 | Inhibitionof microsomal triglyceride transfer protein in familialhypercholesterolemia 显示文摘 | CUCHEL M BLOEDON L T SZAPARY PO | 2007 | N Engl J Med2007，356，2： | 1 |
| 4 | Inhibition of Microsomal Triglyeeride Transfer Protein in Familial Hypercholes- terolemia显示文摘 | CUCHEL M BLOEDON LT SZAPARY PO | 2007 | N Engl J Med2007，356，2： | 1 |
| 5 | Antidiabetic action of bezafibrate in a large observational database 显示文摘 | Flory JH Ellenberg S Szapary PO | 2009 | Diabetes Care2009，32，4： | 1 |
| 6 | Effects of rosiglitazone on lipids, adipokines, and inflammatory markers in nondiabetic patients with low higtvdensity lipoprotein cholesterol and metabolic syndrome 显示文摘 | Samaha FF Szapary PO Iqbal N | 2006 | Arterioscler Thromb Vasc Biol2006，26，3： | 1 |
| 7 | The triglyceride-high-density lipoprotein axis: An important target of therapy 显示文摘 | Szapary PO and Rader DJ | 2004 | America Heart Journal2004，148，： | 1 |
| 8 | Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia显示文摘 | Cuchel M Bloedon LT Szapary PO | | 0，，： | 1 |
| 9 | Effects of pioglitazone on lipoproteins,inflammatory markers,and adipokines in nondiabetic patients with metabolic syndrome显示文摘 | Szapary PO Bloedon LT Samaha FF | 2006 | Arterioscler Thromb VascBiol2006，26，： | 1 |
| 10 | Effects of pioglitazone on lipopmteins,inflammatory markers,and adipokines in nondiabotie patients with metabolic syndrome显示文摘 | Bloedon LT Samaha FF | 2006 | Arterioscler Thromb Vase Biol2006，26，1： | 1 |
| 11 | Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia显示文摘 | Cuchel M Bloedon LT Szapary PO | 2007 | NEngl J Med2007，356，2： | 1 |
| 12 | Effects of piogiitazone on lipoproteins,inflammatory markers, and adipokines in nondi- abetic patients with metabolic syndrome显示文摘 | Szapary PO Bloedon LT Samaha FF | 2006 | Artefioscler Thromb Vasc Biol2006，26，1： | 1 |
| 13 | Effects of rosiglitazone onlipids,adipokines,and inflammatory markers in nondiabeticpatients with low high-density lipoprotein cholesterol and metabolicsyndrome显示文摘 | Samaha FF Szapary PO Iqbal N | 2006 | Arterioscler Thromb Vasc Biol2006，26，3： | 1 |
| 14 | Physical activity and its effects on lipids 显示文摘 | Szapary PO Bloedon LT Foster GD | 2003 | Curr Cardiol Rep2003，5，6： | 1 |
| 15 | Efects of pioglitazone on lipoproteins, inflammatory markers,and adipokines in nondiabetie patients with metabolic syndrome显示文摘 | Szapary PO Bloedon LT Samaha FF | 2006 | Arterioseler Thromb Vase Biol2006，26，1： | 1 |
| 16 | The triglyceride high -density lipoprotein axis an important target of therapy 显示文摘 | Szapary PO Rader DJ | 2014 | Am Heart J2014，148，2： | 1 |
| 17 | Effects of rosiglitazone on lipids, adipokines, and inflammatory markers in nondiabetic patients with low high-density lipoprotein cholesterol and metabolic syndrome显示文摘 | SAMAHA FF SZAPARY PO IQBAL N | 2006 | Arterioscler Thromb Vasc Biol2006，26，： | 1 |
| 18 | The triglyceride-high-density lipoprotein axis:An important target of therapy?显示文摘 | Szapary PO Rader DJ | 2004 | Am Heart J2004，148，2： | 1 |
| 19 | Effects of pioglitazone on lipoproteins,inflammatory markers,and adipokines in nondiabetic patients with metabolic syndrome显示文摘 | Szapary PO Bloedon LT Samaha EF | 2006 | Arterioscler Thromb Vasc Biol2006，26，1： | 1 |
| 20 | Effects of pio- glitazone on lipoproteins, inflammatory markers, and adipo- kines in nondiabetic patients with metabolic syndrome 显示文摘 | Szapary PO Bloedon LT Samaha FF | 2006 | Arterioscler Thromb Vasc Biol2006，26，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员